As Director, Venture Development, Sara guides spinout projects from our research partner institutions through Rev1’s customer, product, and market validation process. She provides extensive guidance to multiple high-growth, high-potential companies, remaining deeply involved for extended periods.
Sara has extensive experience in commercializing innovation—from analyzing complex technologies to determine the market potential to working directly with innovators to advance their projects from laboratory to seed-stage funding. She is an expert in developing commercialization roadmaps, matching technologies to appropriate academic exit strategies, and then assembling the right team to make that happen.
Sara earned a Ph.D. in Biomedical Science from The Ohio State University and a BS degree in Biology from Kent State University.